Skip to the page

Data / Drug companies / Accord Healthcare Inc.

Accord Healthcare Inc.: 234 products in the FDA NDC directory, labeler code 16729

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Accord Healthcare Inc. (labeler code 16729) lists 234 products in the FDA National Drug Code Directory, covering 86 finished drugs by generic name. By type: 228 prescription drugs, 6 drugs for further processing. Its main marketing category is generic drugs (ANDA). The newest product started marketing on August 4, 2026.

The request: Watch Accord Healthcare Inc. (FDA labeler code 16729): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
16729
Products in commercial distribution
234
Packages
389
Finished drugs by generic name
86
Prescription products
228
Over the counter products
0
Controlled substance products
Schedule II 3, Schedule III 2, Schedule IV 3
Flagged as original packager
218 of 218 products that carry the flag
Started marketing in the last 12 months
9
Products with a marketing end date set
1
Earliest marketing start
August 23, 2007
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)22395.3%
Drugs for further processing62.6%
New drug applications (NDA)52.1%

Products by type

TypeProductsShare
Prescription drugs22897.4%
Drugs for further processing62.6%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Levothyroxine sodium1244
Ropinirole720
Temozolomide612
Quetiapine630
Lenalidomide619
Aripiprazole649
Buspirone hydrochloride550
Simvastatin532
Tacrolimus535
Quetiapine fumarate533
Lurasidone hydrochloride528
Pravastatin sodium439
Atorvastatin calcium459
Rosuvastatin419
Doxazosin428
Hydroxychloroquine sulfate433
Trazodone hydrochloride439
Atropine sulfate424
Glycopyrrolate464
Tadalafil454
Pemetrexed39
Diltiazem hydrochloride355
Oxybutynin chloride345
Olmesartan medoxomil and hydrochlorothiazide317
Furosemide363
Glimepiride332
Mitomycin314
Amitriptyline hydrochloride335
Spironolactone345
Cinacalcet318
Escitalopram334
Fluorouracil321
Hydrochlorothiazide351
Olmesartan medoxomil331
Clonazepam336
Methylphenidate hydrochloride339
Vilazodone hydrochloride313
Dofetilide312
Sertraline hydrochloride355
Mycophenolate mofetil237
Bendamustine hydrochloride210
Clozapine213
Prasugrel210
Methotrexate231
Teriflunomide217
Pirfenidone226
Sugammadex222
Finasteride231
Mycophenolic acid216
Paricalcitol213
Allopurinol254
Dimethyl fumarate220
Bupropion hydrochloride267
Carbidopa and levodopa241
Eplerenone212
Daptomycin225
Capecitabine219
Letrozole117
Topotecan13
Dalfampridine111
Ondansetron152
Ezetimibe126
Clomiphene citrate18
Regadenoson114
Bicalutamide19
Etoposide19
Topotecan hydrochloride14
Montelukast sodium131
Dexmedetomidine111
Docetaxel121
Cisplatin111
Fingolimod hydrochloride12
Naltrexone hydrochloride124
Azacitidine120
Acetazolamide137
Busulfan18
Fulvestrant121
Alcohol1293
Anastrozole122
Temsirolimus13
Zoledronic acid118
Bivalirudin113
Carboplatin111
Oxaliplatin116
Decitabine118
Argatroban112

Dosage forms

Dosage formProductsShare
Tablet, film coated7732.9%
Tablet6628.2%
Capsule208.5%
Injection198.1%
Injection, powder, lyophilized, for solution146%
Tablet, extended release125.1%
Injection, solution114.7%
Capsule, extended release41.7%
Tablet, delayed release20.9%
Capsule, delayed release20.9%
Injection, solution, concentrate20.9%
Ointment20.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Sugammadex16729-727Injection, solutionGeneric drugs (ANDA)August 4, 2026
Sugammadex16729-726Injection, solutionGeneric drugs (ANDA)August 4, 2026
Lenalidomide16729-697CapsuleGeneric drugs (ANDA)April 8, 2026
Lenalidomide16729-692CapsuleGeneric drugs (ANDA)April 8, 2026
Lenalidomide16729-695CapsuleGeneric drugs (ANDA)March 2, 2026
Lenalidomide16729-696CapsuleGeneric drugs (ANDA)February 26, 2026
Lenalidomide16729-693CapsuleGeneric drugs (ANDA)February 26, 2026
Lenalidomide16729-694CapsuleGeneric drugs (ANDA)February 17, 2026
Clomiphene Citrate16729-723TabletGeneric drugs (ANDA)November 21, 2025
Dehydrated alcohol16729-710Injection, solutionGeneric drugs (ANDA)June 25, 2025
Teriflunomide16729-400Tablet, film coatedGeneric drugs (ANDA)March 13, 2023
Teriflunomide16729-399Tablet, film coatedGeneric drugs (ANDA)March 13, 2023
Regadenoson16729-477Injection, solutionGeneric drugs (ANDA)March 10, 2023
Lurasidone hydrochloride16729-350Tablet, film coatedGeneric drugs (ANDA)February 20, 2023
Lurasidone hydrochloride16729-349Tablet, film coatedGeneric drugs (ANDA)February 20, 2023
Lurasidone hydrochloride16729-348Tablet, film coatedGeneric drugs (ANDA)February 20, 2023
Lurasidone hydrochloride16729-347Tablet, film coatedGeneric drugs (ANDA)February 20, 2023
Lurasidone hydrochloride16729-346Tablet, film coatedGeneric drugs (ANDA)February 20, 2023
Bendamustine hydrochloride16729-251Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 7, 2022
Bendamustine hydrochloride16729-250Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 7, 2022
Fingolimod hydrochloride16729-342CapsuleGeneric drugs (ANDA)October 18, 2022
Vilazodone Hydrochloride16729-354TabletGeneric drugs (ANDA)June 4, 2022
Vilazodone Hydrochloride16729-353TabletGeneric drugs (ANDA)June 4, 2022
Vilazodone Hydrochloride16729-352TabletGeneric drugs (ANDA)June 4, 2022
Pirfenidone16729-468Tablet, film coatedGeneric drugs (ANDA)May 27, 2022

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.